Lupus care under the microscope: new registry tracks Real-World treatment in kazakhstan
NCT ID NCT06899633
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is a registry that will follow about 500 adults with lupus (SLE) in Kazakhstan to see how the disease behaves and how doctors treat it in everyday practice. Researchers will look at disease activity, organ damage, and which medications are used. No new treatments are being tested—the goal is simply to collect information to better understand lupus care in this region.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this registry could reveal how lupus is actually managed in Kazakhstan, pointing to gaps in care and opportunities to improve treatment guidelines.
- What could go wrong
- This is an observational study, not a treatment trial. It collects data only and cannot directly improve patient outcomes. Results may not apply outside Kazakhstan.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DESCRIPTION OF METHODS AND APPROACHES TO THE TREATMENT OF PATIENTS WITH SLE IN THE REPUBLIC OF KAZAKHSTAN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
ESEM Pharmacy LLP
Almaty, Kazakhstan
-
JSC Research Institute of Cardiology and Internal Diseases
Almaty, Kazakhstan
-
Medical Center for Joint Diseases of Shymkent LLP
Shymkent, Kazakhstan
-
Municipal State Enterprise on the Right of Economic Management - Pavlodar Regional Hospital named after G. Sultanov
Pavlodar, Kazakhstan
-
Municipal state enterprise with the right of economic management City polyclinic No. 5
Almaty, Kazakhstan
-
Non-Profit Joint Stock Company Kazakh National Medical University named after S.D. Asfendiyarov
Almaty, Kazakhstan
-
Non-Profit Joint Stock Company Semey Medical University - University Hospital
Semey, Kazakhstan
-
Republican Diagnostic Center of Astana Corporate Fund University Medical Center
Astana, Kazakhstan
-
State Enterprise on the Right of Economic Management - Aktobe Medical Center
Aktobe, Kazakhstan
-
State Enterprise on the Right of Economic Management - Regional Clinical Hospital of the Turkestan Region
Shymkent, Kazakhstan
-
State-owned enterprise on the right of economic management -Taldykorgan City Polyclinic
Taldykorgan, Kazakhstan
-
Zhambyl Regional Multidisciplinary Hospital of the Health Department of the Akimat of Zhambyl Region
Taraz, -- Select --, Kazakhstan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new biologic tame lupus flares?
- Could a single injection tame lupus and Sjögren's?
- Can a single infusion tame tough lupus?
- Can a single drug calm three different autoimmune diseases? a new trial puts ATG-201 to the test.
- Can genetics and environment explain lupus in the gullah population?
- Can a smartphone app bridge the lupus care gap for women of color?